 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LA JOLLA PHARMACEUTICAL CO (LJPC)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-02 Purchase | 2020-06-04 6:26 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 615,129 | $4.9054 | $3,017,479 | 8,695,474 (Indirect) | View |
| 2020-06-19 Purchase | 2020-06-22 5:16 pm | TETRAPHASE PHARMACEUTICALS INC | TTPH | LA JOLLA PHARMACEUTICAL CO 10% Owner | 234,698 | $2.6161 | $613,993 | 1,085,000 (Direct) | View |
| 2020-07-28 Purchase | 2020-07-29 5:24 pm | TETRAPHASE PHARMACEUTICALS INC | TTPH | LA JOLLA PHARMACEUTICAL CO 10% Owner | 3,737,360 | $2 | $7,474,720 | 4,822,360 (Indirect) | View |
| 2020-08-12 Purchase | 2020-08-14 4:49 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 431,647 | $3.7185 | $1,605,100 | 9,127,121 (Indirect) | View |
| 2020-08-20 Purchase | 2020-08-24 4:22 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director | 47,000 | $3.9884 | $187,456 | 47,000 (Direct) | View |
| 2020-09-04 Purchase | 2020-09-09 6:55 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 278,369 | $3.9402 | $1,096,829 | 9,405,490 (Indirect) | View |
| 2020-09-08 Purchase | 2020-09-10 4:02 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director | 1,000 | $3.83 | $3,830 | 48,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 83 | $7.14 | 83 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 83 | $8.4 | 83 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $7.14 | 229 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $8.4 | 229 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $5.78 | 284 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $6.8 | 284 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 102 | $5.78 | 102 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 102 | $6.8 | 102 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $5.78 | 142 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $6.8 | 142 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:12 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 173 | $3.4 | 173 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:12 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 173 | $4 | 173 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $3.4 | 483 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $4 | 483 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $3.4 | 241 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $4 | 241 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $3.57 | 229 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $4.2 | 229 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $3.57 | 459 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $4.2 | 459 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 165 | $3.57 | 165 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 165 | $4.2 | 165 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $5.61 | 146 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $6.6 | 146 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 350 | $5.61 | 350 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 350 | $6.6 | 350 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $5.61 | 34 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $6.6 | 34 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 58 | $5.61 | 58 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 58 | $6.6 | 58 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 53 | $6.17 | 53 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:08 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 53 | $7.26 | 53 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 319 | $6.17 | 319 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 319 | $7.26 | 319 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $6.17 | 133 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $7.26 | 133 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $5.86 | 140 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $6.89 | 140 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 335 | $5.86 | 335 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 335 | $6.89 | 335 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 56 | $5.86 | 56 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 56 | $6.89 | 56 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 205 | $4.01 | 205 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A 2030-05-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 205 | $4.72 | 205 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 491 | $4.01 | 491 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A 2030-05-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 491 | $4.72 | 491 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 82 | $4.01 | 82 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:03 pm | N/A 2030-05-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 82 | $4.72 | 82 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-03 4:05 pm | N/A 2030-06-01 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S CFO | 100,000 | $4.55 | 100,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 6:26 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 435 | $4.51 | 435 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 6:26 pm | N/A 2030-06-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 435 | $5.31 | 435 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 7:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 543 | $3.62 | 543 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 7:08 pm | N/A 2030-06-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 543 | $4.26 | 543 (Direct) | View |
| 2020-07-15 Option Award | 2020-07-17 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 521 | $3.77 | 521 (Direct) | View |
| 2020-07-15 Option Award | 2020-07-17 4:05 pm | N/A 2030-07-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 521 | $4.44 | 521 (Direct) | View |
| 2020-07-31 Option Award | 2020-08-04 5:24 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 581 | $3.38 | 581 (Direct) | View |
| 2020-07-31 Option Award | 2020-08-04 5:24 pm | N/A 2030-07-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 581 | $3.98 | 581 (Direct) | View |
| 2020-08-14 Option Award | 2020-08-18 5:18 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 589 | $3.34 | 589 (Direct) | View |
| 2020-08-14 Option Award | 2020-08-18 5:18 pm | N/A 2030-08-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 589 | $3.93 | 589 (Direct) | View |
| 2020-08-31 Option Award | 2020-09-02 4:17 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 550 | $3.57 | 550 (Direct) | View |
| 2020-08-31 Option Award | 2020-09-02 4:17 pm | N/A 2030-08-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 550 | $4.2 | 550 (Direct) | View |
| 2020-07-01 Option Award | 2020-09-17 4:57 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 286 | $3.85 | 60,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-09-17 4:57 pm | N/A 2030-09-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 286 | $4.53 | 60,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-09-17 4:57 pm | N/A 2030-07-01 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 60,000 | $4.52 | 60,000 (Direct) | View |
| 2020-10-15 Option Award | 2020-10-19 9:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S CFO | 169 | $3.32 | 169 (Direct) | View |
| 2020-10-15 Option Award | 2020-10-19 9:14 pm | N/A 2030-10-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S CFO | 169 | $3.91 | 169 (Direct) | View |